Sale by Michael York of 107054 shares of MetacrineInc

MTCRDelisted Stock  USD 0.49  0.00  0.00%   
Slightly above 56% of Metacrine's investor base is looking to short. The analysis of current outlook of investing in Metacrine suggests that many traders are alarmed regarding Metacrine's prospects. Metacrine's investing sentiment overview a quick insight into current market opportunities from investing in Metacrine. Many technical investors use Metacrine stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by Metacrine Inc officer. General open market or private sale of non-derivative or derivative security

Read at macroaxis.com
MetacrineInc insider trading alert for sale of common stock by Michael York, Chief Business Officer, on 27th of January 2023. This event was filed by Metacrine Inc with SEC on 2023-01-27. Statement of changes in beneficial ownership - SEC Form 4

Metacrine Fundamental Analysis

We analyze Metacrine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Metacrine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Metacrine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Institutions

Shares Owned By Institutions Comparative Analysis

Metacrine is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Metacrine Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Metacrine stock to make a market-neutral strategy. Peer analysis of Metacrine could also be used in its relative valuation, which is a method of valuing Metacrine by comparing valuation metrics with similar companies.

Peers

Metacrine Related Equities

SRZNSurrozen   19.37   
0%
100.0%
MNPRMonopar Therapeutics   8.84   
0%
45.0%
CTMXCytomX Therapeutics   3.92   
0%
20.0%
VCNXVaccinex   2.44   
0%
12.0%
ASMBAssembly Biosciences   1.25   
0%
6.0%
ANEBAnebulo Pharmaceuticals   0.70   
0%
3.0%
NUVBNuvation Bio   0.35   
0%
1.0%
INDPIndaptus Therapeutics   0.97   
5.0%
0%
TARAProtara Therapeutics   0.99   
5.0%
0%
TILInstil Bio   9.39   
48.0%
0%
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Consideration for investing in Metacrine Stock

If you are still planning to invest in Metacrine check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Metacrine's history and understand the potential risks before investing.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stocks Directory
Find actively traded stocks across global markets